Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Full IRB Study Title:
ALTE2131: Triptorelin and Protection of Ovarian Reserve in Adolescents and Young Adults with Cancer
IRB Study ID: 2025-107
Please view all study details on ClinicalTrials.gov
Study Sponsor:
Children's Oncology Group
We are currently recruiting
If you are interested in this study or have questions about your child's eligibility, please contact:
Kelly Culp
Lead Investigator
Erin Wright, MD
Director, Neuro-Oncology; Director, Shannon E. Wilkes Targeted Therapy Program; Jeffrey A. Barbour Chair for Pediatric Hematology/Oncology Research and Healing; Co-Director, Neurofibromatosis Clinic; Pediatric Neuro-Oncologist
Pediatric Brain Tumor ProgramShowers Family Center for Childhood Cancer and Blood DisordersNeurofibromatosis (NF) Clinic
